This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02169/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02169/identifier/drugbank/
n15http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB02169/identifier/chemspider/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02169/identifier/chebi/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/drugbank/drug/DB02169/identifier/kegg-compound/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02169/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02169/identifier/pubchem-compound/

Statements

Subject Item
n2:DB02169
rdf:type
n3:Drug
n3:description
A specific inhibitor of phosphoserine/threonine protein phosphatase 1 and 2a. It is also a potent tumor promoter. (Thromb Res 1992;67(4):345-54 & Cancer Res 1993;53(2):239-41)
n3:group
experimental
owl:sameAs
n6:DB02169 n15:DB02169
dcterms:title
9,10-Deepithio-9,10-Didehydroacanthifolicin
adms:identifier
n8:7733 n9:4423 n10:46504468 n11:OKA n12:46936318 n13:DB02169 n14:C01945
n3:IUPAC-Name
n4:271B4425-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B442B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B442A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4427-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4428-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4429-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4423-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4421-363D-11E5-9242-09173F13E4C5 n4:271B4424-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4422-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4431-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4432-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B442C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B442D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B442F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B442E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4430-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
78111-17-8
n3:category
n3:Bioavailability
n4:271B4437-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4439-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B443A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4436-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4435-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4438-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4426-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4433-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4434-363D-11E5-9242-09173F13E4C5